Atik Levent, Erdogan Ayten, Karaahmet Elif, Saracli Ozge, Atasoy Nuray, Kurcer Mehmet Ali, Balcioglu Ibrahim
Department of Psychiatry, Zonguldak Karaelmas University, Faculty of Medicine, Zonguldak, Turkey.
Prog Neuropsychopharmacol Biol Psychiatry. 2008 May 15;32(4):968-74. doi: 10.1016/j.pnpbp.2007.12.031. Epub 2008 Jan 11.
The aim of this study is to document the sociodemographic and the clinical profile of patients who are on antipsychotic (AP) medication prescribed in outpatient mental health clinic of a university hospital.
A retrospective chart review was conducted for all outpatient files between 2005 and 2006 at the Zonguldak Karaelmas University, Medical Faculty Hospital, Department of Psychiatry in Turkey. All patients prescribed AP with regular follow up were recruited for the study. The type of AP and the route of administration were recorded. The diagnosis, age and gender of the patients were also evaluated.
We reviewed 1606 patients' files. APs were prescribed in 27.6% of the patients. Atypical antipsychotics (AAPs) represented 75.1% and typical antipsychotics (TAPs) represented 24.9% of all antipsychotic prescriptions in our study. The main psychiatric diagnoses associated with a TAP prescription were: psychotic disorders (6.5%), major affective disorders (49.5%), anxiety disorders (36.4%), and other psychiatric diseases (7.4%). The main psychiatric diagnoses associated with an AAP prescription were: psychotic disorders (35.1%), major affective disorders (31.1%), anxiety disorders (27.8%), somatoform disorders (2.4%) and other psychiatric diseases (6.4%). Twenty-eight of these patients (6.3%) were prescribed more than one AP, 45 patients were prescribed mood stabilizer (10.2%) and 272 patients were prescribed antidepressant agents (61.2%) in addition to AP.
The results reflect the particular use of AAPs in present study population. In line with the published data, the results of this study show that AAPs and TAPs are widely used in those with major affective disorders and psychotic disorders. These findings also underline the widespread off-label use of APs in the treatment of other psychiatric disorders.
本研究旨在记录在某大学医院门诊心理健康诊所开具抗精神病药物(AP)的患者的社会人口统计学和临床特征。
对土耳其宗古尔达克卡拉埃尔马斯大学医学院医院精神病科2005年至2006年期间的所有门诊病历进行回顾性图表审查。纳入所有定期随访且开具了AP的患者进行研究。记录AP的类型和给药途径。还评估了患者的诊断、年龄和性别。
我们审查了1606份患者病历。27.6%的患者开具了AP。在我们的研究中,非典型抗精神病药物(AAPs)占所有抗精神病药物处方的75.1%,典型抗精神病药物(TAPs)占24.9%。与TAP处方相关的主要精神疾病诊断为:精神障碍(6.5%)、重度情感障碍(49.5%)、焦虑障碍(36.4%)和其他精神疾病(7.4%)。与AAP处方相关的主要精神疾病诊断为:精神障碍(35.1%)、重度情感障碍(31.1%)、焦虑障碍(27.8%)、躯体形式障碍(2.4%)和其他精神疾病(6.4%)。这些患者中有28名(6.3%)开具了不止一种AP,45名患者开具了情绪稳定剂(10.2%),272名患者除AP外还开具了抗抑郁药(61.2%)。
结果反映了本研究人群中AAPs的特殊使用情况。与已发表的数据一致,本研究结果表明,AAPs和TAPs在重度情感障碍和精神障碍患者中广泛使用。这些发现还强调了AP在治疗其他精神疾病时广泛的超说明书用药情况。